UnknownNot applicableNCT03469518

Effect of β-cryptoxanthin (β-Cx), Plant Sterols and Galactooligosaccharides on Systemic and Gastrointestinal Markers

Studying Sterol metabolism disorder

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Puerta de Hierro University Hospital
Principal Investigator
Fernando Granado Lorencio, PhD
Hospital Universitario Puerta de Hierro-Majadahonda
Intervention
β-Cx plus PS plus GOS(dietary_supplement)
Enrollment
40 target
Eligibility
45-65 years · FEMALE
Timeline
2017 – 2019

Collaborators

Nutrition and Food Science Area, Faculty of Pharmacy, University of Valencia · Global Technology centro, Hero Group · Fundación para la Investigación Biomédica, Hospital Universitario Puerta de Hierro

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03469518 on ClinicalTrials.gov

Other trials for Sterol metabolism disorder

Additional recruiting or active studies for the same condition.

See all trials for Sterol metabolism disorder →

← Back to all trials